Omeros

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Omeros and other ETFs, options, and stocks.

About OMER

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. 

CEO
Gregory A. Demopulos
CEOGregory A. Demopulos
Employees
175
Employees175
Headquarters
Seattle, Washington
HeadquartersSeattle, Washington
Founded
1994
Founded1994
Employees
175
Employees175

OMER Key Statistics

Market cap
1.25B
Market cap1.25B
Price-Earnings ratio
12.07
Price-Earnings ratio12.07
Dividend yield
Dividend yield
Average volume
3.09M
Average volume3.09M
High today
$17.30
High today$17.30
Low today
$16.90
Low today$16.90
Open price
$17.18
Open price$17.18
Volume
1.23M
Volume1.23M
52 Week high
$18.14
52 Week high$18.14
52 Week low
$3.94
52 Week low$3.94

Stock Snapshot

As of today, Omeros(OMER) shares are valued at $17.10. The company's market cap stands at 1.25B, with a P/E ratio of 12.07.

On 2026-08-18, Omeros(OMER) stock moved within a range of $16.90 to $17.30. With shares now at $17.10, the stock is trading +1.2% above its intraday low and -1.2% below the session's peak.

Trading volume for Omeros(OMER) stock has reached 1.23M, versus its average volume of 3.09M.

The stock's 52-week range extends from a low of $3.94 to a high of $18.14.

The stock's 52-week range extends from a low of $3.94 to a high of $18.14.

OMER News

Simply Wall St 22h
Why Omeros Is Up 27.5% After Swinging To Profitability And Completing Share Buyback

Omeros Corporation recently reported second-quarter and half-year 2026 results showing a move from net losses to net income of US$13.23 million and US$69.29 mil...

Why Omeros Is Up 27.5% After Swinging To Profitability And Completing Share Buyback
TipRanks 5d
Omeros Appoints Veteran Investor Joseph Schocken to Board

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...

TipRanks 5d
Omeros Maintained at Buy as Strong YARTEMLEA Launch and Reduced C5 Competition Support Unchanged $33 Price Target

H.C. Wainwright analyst Brandon Folkes reiterated a Buy rating on Omeros today and set a price target of $33.00. Unlock powerful investing tools with TipRanks...

More OMER News

TipRanks 6d
Omeros Earnings Call: Yartemlia Surge and Leaner Balance Sheet

Omeros Corporation ((OMER)) has held its Q2 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock powerful investing tools w...

People also own

Based on the portfolios of people who own OMER. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.